Your browser is no longer supported. Please, upgrade your browser.
IDXX IDEXX Laboratories, Inc. monthly Stock Chart
IDXX [NASD]
IDEXX Laboratories, Inc.
IndexS&P 500 P/E57.84 EPS (ttm)3.80 Insider Own1.30% Shs Outstand88.94M Perf Week1.33%
Market Cap19.55B Forward P/E45.52 EPS next Y4.83 Insider Trans-6.62% Shs Float85.04M Perf Month-8.85%
Income337.90M PEG2.56 EPS next Q0.97 Inst Own89.80% Short Float1.19% Perf Quarter-11.40%
Sales2.12B P/S9.24 EPS this Y34.40% Inst Trans0.51% Short Ratio2.18 Perf Half Y13.38%
Book/sh-0.47 P/B- EPS next Y15.64% ROA19.30% Target Price264.80 Perf Year33.43%
Cash/sh1.96 P/C111.95 EPS next 5Y22.56% ROE-635.70% 52W Range146.09 - 256.22 Perf YTD40.54%
Dividend- P/FCF66.04 EPS past 5Y15.70% ROI29.60% 52W High-14.22% Beta0.73
Dividend %- Quick Ratio0.70 Sales past 5Y8.80% Gross Margin55.80% 52W Low50.44% ATR6.54
Employees7600 Current Ratio1.00 Sales Q/Q14.10% Oper. Margin21.60% RSI (14)38.96 Volatility3.22% 2.80%
OptionableYes Debt/Eq- EPS Q/Q29.20% Profit Margin14.50% Rel Volume0.92 Prev Close218.40
ShortableYes LT Debt/Eq- EarningsNov 01 BMO Payout0.00% Avg Volume466.16K Price219.78
Recom1.90 SMA20-5.23% SMA50-8.52% SMA2003.03% Volume428,209 Change0.63%
May-07-18Reiterated Stifel Buy $215 → $225
Jan-16-18Initiated Piper Jaffray Overweight $200
Aug-23-17Upgrade BofA/Merrill Neutral → Buy
Jul-28-17Upgrade CL King Neutral → Buy
Feb-03-17Downgrade Feltl & Co. Hold → Sell
Sep-29-16Resumed BofA/Merrill Neutral
Aug-16-16Reiterated Stifel Buy $120 → $125
Aug-03-16Upgrade Northcoast Sell → Neutral
Jul-20-16Reiterated Canaccord Genuity Buy $90 → $98
Apr-19-16Reiterated Canaccord Genuity Buy $80 → $85
Apr-01-16Initiated CL King Neutral
Mar-21-16Reiterated Stifel Buy $80 → $85
Feb-04-16Initiated Credit Suisse Outperform
Oct-29-15Reiterated Stifel Buy $85 → $80
Aug-28-15Downgrade Raymond James Outperform → Mkt Perform
Aug-13-15Reiterated Stifel Buy $78 → $85
Jul-23-15Reiterated Canaccord Genuity Buy $80 → $75
Apr-29-15Reiterated Stifel Buy $178 → $155
Jan-22-15Reiterated Canaccord Genuity Buy $160 → $175
Jan-16-15Reiterated Stifel Buy $155 → $178
Oct-16-18 07:22PM  Cramer's 5 health-care stocks he likes right now CNBC Videos
07:02PM  Cramer reveals 5 health-care stocks he likes right now, i... CNBC Videos
06:35PM  Cramer reveals 5 health-care stocks he likes right now, including UnitedHealth and HCA CNBC
Oct-12-18 12:05PM  Putting IDEXX Laboratories Stock Under the Microscope TheStreet.com
Oct-11-18 07:14PM  Beaten-down tech stocks ripe for the picking CNBC Videos
06:53PM  Cramer finds beaten-down tech stocks ripe for the picking... CNBC Videos
07:30AM  Market Trends Toward New Normal in Altra Industrial Motion, IDEXX Laboratories, BioTelemetry, Galectin Therapeutics, NETGEAR, and Merck & Co. Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Oct-01-18 01:30PM  10 High-Margin Stocks To Survive The U.S.-China Trade War Investopedia
Sep-24-18 06:54PM  Cramer advises staying away from animal health play Elanc... CNBC Videos
10:00AM  IDEXX Laboratories to Release 2018 Third Quarter Financial Results PR Newswire
Sep-13-18 09:23AM  Here's Why You Should Retain IDEXX (IDXX) in Your Portfolio Zacks
Sep-11-18 10:40AM  3 Hidden Gems in the Nasdaq-100 Investopedia
Sep-10-18 08:12AM  IDEXX Gains Ground on Solid CAG Business Amid Forex Woes Zacks
07:30AM  IDEXX Pseudalert Test Accepted as Global ISO Standard PR Newswire
Sep-01-18 01:05AM  Why Is Idexx (IDXX) Up 5.3% Since Last Earnings Report? Zacks
Aug-28-18 03:07PM  Nasdaq ETF Hits New Highs: 5 Stocks Up More Than 50% InvestorPlace
Aug-23-18 09:15PM  Idexx Laboratories Inc (IDXX) Chairman, President & CEO Jonathan W Ayers Sold $7. ... GuruFocus.com
Aug-19-18 06:12PM  Why Amazon Could Soon Join 3 Hot IBD 50 Growth Stocks In This Rare Bullish Pattern Investor's Business Daily
Aug-16-18 04:55PM  IBD 50 Stocks To Watch: Idexx Stock, Up 56% This Year, Poised For Breakout Investor's Business Daily
Aug-15-18 07:30AM  IDEXX Reference Laboratories Significantly Expands Rapid Overnight Service for Thousands of U.S. Veterinary Practices PR Newswire
Aug-10-18 07:00PM  Cramers Exec Cut: The rise of esports, cryptomining and ... CNBC Videos
10:22AM  Oppenheimer Funds Standout Wins With Diversified Portfolio Investor's Business Daily
Aug-09-18 02:16PM  IDEXX Laboratories Is Not Responding to Bullish News TheStreet.com
Aug-08-18 07:00PM  Cramer Remix: Even the Death Star cant wipe out an industry overnight CNBC
06:58PM  Preventative care for pets a major long-term growth drive... CNBC Videos
Aug-06-18 02:00PM  IDEXX Laboratories to Host 2018 Investor Day PR Newswire
07:30AM  Detailed Research: Economic Perspectives on A10 Networks, Lannett, Navigant Consulting, EastGroup Properties, Lennox International, and IDEXX Laboratories What Drives Growth in Today's Competitive Landscape GlobeNewswire
Aug-03-18 03:40PM  IDEXX Laboratories Has Been a Real Keeper But a Correction Could Be Coming TheStreet.com
02:42PM  IDEXX Laboratories Is as Fit as a Butcher's Dog Motley Fool
Aug-01-18 03:50PM  IDEXX Laboratories (IDXX) Beats on Q2 Earnings, EPS View Up Zacks
01:19PM  Edited Transcript of IDXX earnings conference call or presentation 1-Aug-18 12:30pm GMT Thomson Reuters StreetEvents
10:02AM  IDEXX Laboratories, Inc. (IDXX) Q2 2018 Earnings Conference Call Transcript Motley Fool
08:33AM  IDEXX Laboratories (IDXX) Beats on Q2 Earnings and Revenues Zacks
08:16AM  Idexx Laboratories (IDXX) Tops Q2 Earnings and Revenue Estimates Zacks
06:39AM  Idexx: 2Q Earnings Snapshot Associated Press
06:30AM  IDEXX Laboratories, Inc. to Host Earnings Call ACCESSWIRE
06:30AM  IDEXX Laboratories Announces Second Quarter Results PR Newswire
Jul-23-18 11:22AM  Can CAG Growth Continue to Aid IDEXX (IDXX) in Q2 Earnings? Zacks
Jul-17-18 07:30AM  Free Pre-Market Technical Recap on TherapeuticsMD and Three Additional Healthcare Stocks ACCESSWIRE
Jul-05-18 03:41PM  MASI or STE: Which Is a Better Investment Option Right Now? Zacks
11:45AM  IDEXX Laboratories to Release 2018 Second Quarter Financial Results PR Newswire
Jun-26-18 09:37AM  Medical Device Firms in Focus on Expanded R&D Scope: 5 Picks Zacks
Jun-25-18 11:43AM  IDEXX Laboratories Global Growth Solid on Catalyst Uptake Zacks
09:30AM  Has IDEXX Laboratories (IDXX) Outpaced Other Medical Stocks This Year? Zacks
Jun-20-18 08:24AM  BSX or BAX: Which is a Better Pick for Your Portfolio Now? Zacks
Jun-19-18 07:20AM  The 6 Stocks on the MFM Team's Radar This Week Motley Fool
Jun-15-18 10:39AM  Top Analyst Reports for Phillip Morris, Tesla & Simon Property Group Zacks
Jun-07-18 11:07AM  Why You Should Add IDEXX (IDXX) Stock to Your Portfolio? Zacks
Jun-06-18 07:30AM  Stock Performance Review on TherapeuticsMD and Three Other Healthcare Stocks ACCESSWIRE
Jun-05-18 11:35AM  IDEXX Laboratories to Present at William Blair Growth Stock Conference PR Newswire
Jun-04-18 04:55AM  IDEXX Laboratories (IDXX) Up 6.4% Since Earnings Report: Can It Continue? Zacks
May-31-18 08:36AM  Time to Focus on IDEXX Laboratories (IDXX) for Strong Earnings Growth Potential Zacks
May-28-18 01:30PM  IDEXX's (IDXX) Catalyst Uptake Remains Strong & Boosts CAG Zacks
May-25-18 12:56PM  Idexx: Putting Man's Best Friend In A 'Spectacular Industry'? Investor's Business Daily
May-21-18 04:26PM  IDEXX Laboratories to Present at Stifel 2018 Dental and Veterinary Conference PR Newswire
May-16-18 06:17PM  After the Bell: Dow Gains 63 Because Higher Bond Yields Don't Matter After All Barrons.com
05:52PM  Edited Transcript of IDXX earnings conference call or presentation 4-May-18 12:30pm GMT Thomson Reuters StreetEvents
May-14-18 07:15AM  Jim Cramer Shares His Thoughts On Xerox, Booking Holdings And More Benzinga
May-11-18 04:47PM  IDEXX Laboratories Barks Out Another Successful Quarter Motley Fool
May-09-18 08:59PM  The 3 Stocks on the MFM Team's Radar This Week Motley Fool
May-07-18 04:03PM  Apple Leads Five Hot Stocks Now In Buy Range Investor's Business Daily
01:47PM  Idexx Laboratories (IDXX) Q1 2018 Earnings Conference Call Transcript Motley Fool
08:34AM  IDEXX (IDXX) Hits a 52-Week High, Can the Run Continue? Zacks
May-04-18 04:58PM  This Top Medical Stock Breaks Out After Its Beat-And-Raise Investor's Business Daily +8.39%
02:45PM  IDEXX Laboratories (IDXX) Earnings, Revenues Rise in Q1 Zacks
09:25AM  Zacks.com highlights: Louisiana-Pacific, IDEXX Laboratories, SolarEdge Technologies, Curtiss-Wright and Autohome Zacks
07:15AM  IDEXX Laboratories (IDXX) Beats on Q1 Revenues, View Upbeat Zacks
06:54AM  Idexx: 1Q Earnings Snapshot Associated Press
06:45AM  IDEXX Laboratories, Inc. to Host Earnings Call ACCESSWIRE
06:30AM  IDEXX Laboratories Announces First Quarter Results PR Newswire
May-03-18 10:45AM  Invest in These 5 Low Leverage Stocks to Earn Steady Returns Zacks
Apr-30-18 08:15AM  Research Report Identifies Cara Therapeutics, MGE Energy, IDEXX Laboratories, Sterling Construction, TTM Technologies, and Regis with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Apr-24-18 11:40AM  Can CAG Growth for IDEXX (IDXX) Stock Return in Q1 Earnings? Zacks
Apr-12-18 04:00PM  IDEXX Laboratories to Release 2018 First Quarter Financial Results PR Newswire
Apr-10-18 03:02PM  Edited Transcript of IDXX presentation 6-Mar-17 3:25pm GMT Thomson Reuters StreetEvents
Apr-02-18 07:47AM  The Zacks Analyst Blog Highlights: Seagate Technology, Micron Technology, IDEXX Laboratories, Kohl's and Motorola Solutions Zacks
Mar-29-18 08:29AM  5 Top-Performing S&P 500 Stocks of Q1 Zacks
Mar-22-18 10:54AM  Why Should You Add IDEXX (IDXX) Stock to Your Portfolio? Zacks
Mar-12-18 11:32AM  IDEXX Laboratories Gains on Solid Prospects & CAG Business Zacks
Feb-26-18 06:59PM  Cramer's lightning round: My biggest worry about Allergan CNBC Videos
Feb-20-18 10:09AM  Here's Why You Should Invest in IDEXX Laboratories (IDXX) Now Zacks
Feb-16-18 03:48PM  IDEXX Laboratories Inc (IDXX) Files 10-K for the Fiscal Year Ended on December 31, 2017 GuruFocus.com
Feb-15-18 02:30PM  IDEXX Laboratories to Present at Two Conferences PR Newswire
Feb-09-18 05:43PM  Edited Transcript of IDXX earnings conference call or presentation 1-Feb-18 1:30pm GMT Thomson Reuters StreetEvents
Feb-07-18 07:15PM  Idexx Laboratories Inc (IDXX) Chairman, President & CEO Jonathan W Ayers Sold $6. ... GuruFocus.com
08:14AM  Zacks.com featured highlights include: Lululemon, Exelixis, IDEXX, Teradyne and Pioneer Natural Zacks
Feb-06-18 09:23AM  5 of the Best Efficient Stocks for Your Portfolio Zacks
08:55AM  Second Sight (EYES) Catches Eye: Stock Jumps 12.7% Zacks
08:21AM  IDEXX Laboratories Strong on CAG Business Amid Currency Woes Zacks
Feb-05-18 03:31PM  IDEXX Laboratories Separates From the Pack Motley Fool
07:30AM  IDEXX Advances Power of SediVue Dx with Latest Software Update PR Newswire
07:30AM  IDEXX Advances Power of SediVue Dx with Latest Software Update CNW Group
Feb-01-18 06:40PM  Cramer pinpoints 4 stocks 'on a mission' to higher prices... CNBC Videos
06:36PM  Cramer: Boeing, Nvidia, Mastercard, Idexx all headed high... CNBC Videos
11:25AM  IDEXX Laboratories (IDXX) Beats on Q4 Earnings and Revenues Zacks
08:23AM  IDEXX Laboratories (IDXX) Beats on Q4 Revenues, View Up Zacks
07:03AM  Idexx beats Street 4Q forecasts Associated Press
06:50AM  IDEXX Laboratories, Inc. to Host Earnings Call ACCESSWIRE
06:30AM  IDEXX Laboratories Announces Fourth Quarter and Full Year 2017 Results PR Newswire
Jan-31-18 10:24AM  Medical Device Stocks Earnings Due on Feb 1: BSX, BAX & More Zacks
IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. The company provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. It also offers diagnostic and health-monitoring products for livestock, poultry, and dairy markets; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers that are used in the human point-of-care medical diagnostics market. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was founded in 1983 and is headquartered in Westbrook, Maine.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Studer JacquelineCVP, Gen. Counsel & SecretaryAug 31Option Exercise0.001,12908,763Sep 04 05:05 PM
AYERS JONATHAN WChairman, President & CEOAug 28Option Exercise43.7130,0001,311,3001,103,469Aug 30 05:04 PM
AYERS JONATHAN WChairman, President & CEOAug 23Option Exercise43.7110,000437,1001,080,469Aug 23 06:02 PM
TWIGGE GIOVANICORPORATE VICE PRESIDENTAug 23Option Exercise44.754,466199,85218,640Aug 23 06:04 PM
AYERS JONATHAN WChairman, President & CEOAug 23Sale247.337,0001,731,2901,073,469Aug 23 06:02 PM
AYERS JONATHAN WChairman, President & CEOAug 22Option Exercise43.7120,000874,2001,086,469Aug 23 06:02 PM
AYERS JONATHAN WChairman, President & CEOAug 22Sale245.7116,0003,931,4371,070,469Aug 23 06:02 PM
Lane MichaelCorporate Vice PresidentAug 21Option Exercise70.195,838409,7759,245Aug 23 06:03 PM
Studer JacquelineCVP, Gen. Counsel & SecretaryAug 21Option Exercise81.9311,619952,00019,253Aug 23 06:03 PM
AYERS JONATHAN WChairman, President & CEOAug 21Option Exercise43.7110,000437,1001,073,469Aug 23 06:02 PM
TWIGGE GIOVANICORPORATE VICE PRESIDENTAug 21Option Exercise43.7111,372497,07025,546Aug 23 06:04 PM
TWIGGE GIOVANICORPORATE VICE PRESIDENTAug 21Sale242.7111,3722,760,07214,174Aug 23 06:04 PM
Lane MichaelCorporate Vice PresidentAug 21Sale243.785,9121,441,2113,333Aug 23 06:03 PM
Studer JacquelineCVP, Gen. Counsel & SecretaryAug 21Sale244.0311,6192,835,3757,634Aug 23 06:03 PM
AYERS JONATHAN WChairman, President & CEOAug 21Sale243.207,0001,702,4181,066,469Aug 23 06:02 PM
Studer JacquelineCVP, Gen. Counsel & SecretaryAug 08Option Exercise79.531,785141,9567,634Aug 10 05:03 PM
Studer JacquelineCVP, Gen. Counsel & SecretaryAug 06Option Exercise79.548,598683,88514,447Aug 07 06:02 PM
Studer JacquelineCVP, Gen. Counsel & SecretaryAug 06Sale242.378,5982,083,8715,849Aug 07 06:02 PM
Vandebroek Sophie V.DirectorAug 03Option Exercise55.855,938331,64310,598Aug 07 06:01 PM
Claflin Bruce L.DirectorAug 03Buy242.12415100,4801,415Aug 07 06:00 PM
Vandebroek Sophie V.DirectorAug 03Sale240.643,265785,6957,612Aug 07 06:01 PM
Turner Kathy VCorporate Vice PresidentJun 01Option Exercise0.0046603,272Jun 04 05:07 PM
Studer JacquelineCVP, Gen. Counsel & SecretaryMay 30Option Exercise79.541,18594,2556,300May 31 05:44 PM
Studer JacquelineCVP, Gen. Counsel & SecretaryMay 30Sale209.9847599,7415,825May 31 05:44 PM
TWIGGE GIOVANICORPORATE VICE PRESIDENTMay 29Sale204.371,626332,30614,150May 31 05:44 PM
END WILLIAM TDirectorMay 10Sale208.369,4701,973,16331,786May 11 06:59 PM
JUNIUS DANIEL MDirectorFeb 28Option Exercise64.692,974192,3885,602Mar 02 05:01 PM
JUNIUS DANIEL MDirectorFeb 28Sale190.062,974565,2322,628Mar 02 05:01 PM
END WILLIAM TDirectorFeb 22Sale184.484,000737,93941,256Feb 23 05:04 PM
AYERS JONATHAN WChairman, President & CEOFeb 16Option Exercise45.842,18099,9311,063,398Feb 20 07:29 PM
AYERS JONATHAN WChairman, President & CEOFeb 14Option Exercise0.003,93401,063,046Feb 16 08:00 PM
MCKEON BRIAN PExecutive VP & CFOFeb 14Option Exercise0.002,625044,943Feb 16 08:02 PM
TWIGGE GIOVANICORPORATE VICE PRESIDENTFeb 14Option Exercise0.001,572016,213Feb 16 08:03 PM
MAZELSKY JAYExecutive Vice PresidentFeb 14Option Exercise0.002,615021,538Feb 16 08:01 PM
Studer JacquelineCVP, Gen. Counsel & SecretaryFeb 14Option Exercise0.0096405,375Feb 16 08:02 PM
Kingsley Lawrence DDirectorFeb 14Buy178.051,000178,0454,558Feb 16 06:08 PM
MCKEON BRIAN PExecutive VP & CFOFeb 09Option Exercise53.191,88099,98842,318Feb 13 05:30 PM
AYERS JONATHAN WChairman, President & CEOFeb 08Option Exercise38.804,000155,1801,063,112Feb 09 06:01 PM
AYERS JONATHAN WChairman, President & CEOFeb 08Sale175.344,000701,3571,059,112Feb 09 06:01 PM
AYERS JONATHAN WChairman, President & CEOFeb 07Option Exercise38.8018,000698,3101,077,112Feb 09 06:01 PM
Claflin Bruce L.DirectorFeb 07Buy179.581,000179,5801,000Feb 09 06:02 PM
AYERS JONATHAN WChairman, President & CEOFeb 07Sale178.0018,0003,204,0261,059,112Feb 09 06:01 PM
AYERS JONATHAN WChairman, President & CEOFeb 06Option Exercise38.8018,000698,3101,077,112Feb 07 06:09 PM
AYERS JONATHAN WChairman, President & CEOFeb 06Sale176.6318,0003,179,3621,059,112Feb 07 06:09 PM
AYERS JONATHAN WChairman, President & CEOFeb 05Option Exercise38.8018,000698,3101,077,112Feb 07 06:09 PM
MCKEON BRIAN PExecutive VP & CFOFeb 05Option Exercise38.806,602256,12547,040Feb 07 06:09 PM
MCKEON BRIAN PExecutive VP & CFOFeb 05Sale181.366,6021,197,36940,438Feb 07 06:09 PM
AYERS JONATHAN WChairman, President & CEOFeb 05Sale181.9218,0003,274,6121,059,112Feb 07 06:09 PM
AYERS JONATHAN WChairman, President & CEOJan 11Option Exercise38.8018,000698,3101,077,112Jan 11 06:11 PM
AYERS JONATHAN WChairman, President & CEOJan 11Sale167.032,160360,7811,074,952Jan 11 06:11 PM
AYERS JONATHAN WChairman, President & CEOJan 10Option Exercise38.8018,000698,3101,077,112Jan 11 06:11 PM
AYERS JONATHAN WChairman, President & CEOJan 10Sale164.8818,0002,967,8081,059,112Jan 11 06:11 PM
AYERS JONATHAN WChairman, President & CEOJan 09Option Exercise38.8018,000698,3101,077,112Jan 11 06:11 PM
AYERS JONATHAN WChairman, President & CEOJan 09Sale165.1518,0002,972,6301,059,112Jan 11 06:11 PM
AYERS JONATHAN WChairman, President & CEOJan 03Option Exercise38.8012,500484,9381,059,112Jan 05 06:00 PM
MCKEON BRIAN PExecutive VP & CFOJan 01Option Exercise0.002,820041,533Jan 03 05:55 PM
MAZELSKY JAYExecutive Vice PresidentDec 05Option Exercise0.00961019,355Dec 07 05:33 PM
TWIGGE GIOVANIChief Human Resources OfficerNov 30Sale156.072,000312,13714,402Dec 04 06:00 PM
AYERS JONATHAN WChairman, President & CEONov 16Option Exercise38.8018,000698,3101,064,573Nov 16 09:04 PM
AYERS JONATHAN WChairman, President & CEONov 16Sale153.6118,0002,764,9021,046,573Nov 16 09:04 PM
AYERS JONATHAN WChairman, President & CEONov 15Option Exercise38.8018,000698,3101,064,573Nov 16 09:04 PM
AYERS JONATHAN WChairman, President & CEONov 15Sale149.6118,0002,692,9541,046,573Nov 16 09:04 PM
AYERS JONATHAN WChairman, President & CEONov 14Option Exercise38.8018,000698,3101,064,573Nov 16 09:04 PM
AYERS JONATHAN WChairman, President & CEONov 14Sale148.3518,0002,670,2801,046,573Nov 16 09:04 PM
AYERS JONATHAN WChairman, President & CEONov 07Option Exercise38.7518,000697,5001,064,573Nov 07 05:31 PM
AYERS JONATHAN WChairman, President & CEONov 07Sale148.7718,0002,677,8011,046,573Nov 07 05:31 PM
AYERS JONATHAN WChairman, President & CEONov 06Option Exercise38.7518,000697,5001,064,573Nov 07 05:31 PM
AYERS JONATHAN WChairman, President & CEONov 06Sale151.4618,0002,726,2341,046,573Nov 07 05:31 PM
AYERS JONATHAN WChairman, President & CEONov 03Option Exercise38.7518,000697,5001,064,573Nov 07 05:31 PM
AYERS JONATHAN WChairman, President & CEONov 03Sale153.7518,0002,767,4131,046,573Nov 07 05:31 PM
AYERS JONATHAN WChairman, President & CEONov 02Option Exercise38.7512,500484,3751,046,573Nov 06 05:20 PM